Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 05, 2022
Founded in 2002, Brightech specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to Everest, Brightech has earned a highly-regarded reputation as a critical partner for some of the world’s largest...
read more
Monday, December 05, 2022
Lonza announced the start of new mid-scale manufacturing assets at its API manufacturing center in Nansha, China.
read more
Friday, December 02, 2022
Alcami announced that the build-out is underway of a new 65,000-square-foot cGMP biostorage facility.
read more
Friday, December 02, 2022
Reaction Biology Corporation announced that the Company has closed on a definitive agreement for Reaction to acquire Bioassay Labor für biologische Analytik GmbH ("Bioassay"), including its wholly-owned subsidiary, Peptide Specialty Laboratories GmbH...
read more
Friday, December 02, 2022
Catalent announced that it has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
read more
Friday, December 02, 2022
Innoforce announced that it has commenced GMP manufacturing at its new site in Hangzhou, China. The new facility is built to offer process development & manufacturing services for the global supply of RNA, plasmid DNA, viral vectors, and cell ...
read more
Thursday, December 01, 2022
Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, continues to scale and expand its commercial operations with the appointment of Jeff Whitmore ...
read more
Thursday, December 01, 2022
WuXi STA, a subsidiary of WuXi AppTec announced the partnership with Multiply Labs (based in San Francisco, CA, USA), a robotics company that has developed industry-leading automated manufacturing systems to produce individualized drugs.
read more
Thursday, December 01, 2022
As part of the Decentralized Trials and Research Alliance’s (DTRA) TGIF-DCT podcast series, global MedTech and patient servicing provider mdgroup join global clinical trial laboratory Q2 Solutions to explain how uniting vendors and service providers ...
read more
Thursday, December 01, 2022
August Bioservices, a CDMO providing drug discovery, development and pharmaceutical manufacturing services, announced $65 million in Series B funding led by Oak HC/FT, who led the Series A in July 2020. This round includes participation from existing...
read more
Thursday, December 01, 2022
Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian-expressed protein therapeutics, announced it has been granted a license to ATUM’s proprietary Leap-In Transposase...
read more
Tuesday, November 29, 2022
Lonza and AbTis, a Korean biotechnology company announced that the companies are collaborating to advance the precision of bioconjugation strategies for novel bioconjugates-based therapies.
read more
Tuesday, November 29, 2022
Immutep Limited has signed a Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer for a new Phase I clinical study in patients with urothelial cancer, called INSIGHT-005.
read more
Tuesday, November 29, 2022
ValGenesis, Inc and LifeBee have partnered to deliver business consulting and innovative digital validation solutions in GxP regulated areas such as manufacturing, quality assurance,
read more
Tuesday, November 29, 2022
Kaneka Corporation will manufacture and supply intermediates to Shionogi & Co., Ltd. for use in Xocova® (Ensitrelvir Fumaric Acid) Tablets 125mg, a drug for the treatment of SARS-Cov-2 infection.
read more